Drug intelligence / Profile preview

Revolax

Development stage
Unknown
Lead developer
ACROSS Group
Administration
Injection
01

Overview

Revolax is a family of cross-linked hyaluronic acid (HA) dermal fillers developed and manufactured by the South Korean company Across. It is designed for aesthetic soft-tissue augmentation, including the correction of facial wrinkles, lip enhancement, and facial contouring. The filler is composed of high-purity, non-animal-based hyaluronic acid and features a monophasic structure with a dense lattice, which provides consistent injection pressure and enhanced durability within the tissue. Revolax is available in several formulations—Fine, Deep, and Sub-Q—which differ in their viscoelastic properties and are tailored for specific injection depths and treatment areas. While often distributed by e-commerce platforms like CelestaPro, the product is a globally recognized medical aesthetic injectable.

Brand names
Revolax FineRevolax DeepRevolax Sub-Q
Other names
Revolax with LidocaineHyaluronic acid dermal filler

Beyond the preview

Go deeper on Revolax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revolax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call